1. Peripheral Nervous, Hepatic, and Gastrointestinal Endpoints for AL Amyloidosis Clinical Trials: Report from the Amyloidosis Forum Multi-organ System Working Group

   • Michelle L. Mauermann
   • John O. Clarke
   • the Amyloidosis Forum Working Group Participants

   Review Open access 02 September 2023 Pages: 4695 - 4710

   

2. Unmet Needs in the Treatment of Childhood Type 2 Diabetes: A Narrative Review

   • William Tamborlane
   • Naim Shehadeh

   Review Open access 05 September 2023 Pages: 4711 - 4720

3. Efficacy of Biologics in Patients with Allergic Severe Asthma, Overall and by Blood Eosinophil Count: A Literature Review

   • Jonathan A. Bernstein
   • Jean-Pierre Llanos
   • Christopher S. Ambrose

   Review Open access 12 September 2023 Pages: 4721 - 4740

   

4. Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review

   • Roger R. Dmochowski
   • Diane K. Newman
   • A. Lenore Ackerman

   Review Open access 19 September 2023 Pages: 4741 - 4757

5. The Adherence and Outcomes Benefits of Using a Connected, Reusable Auto-Injector for Self-Injecting Biologics: A Narrative Review

   • Attila Antalfy
   • Kyle Berman
   • Charles M. Godfrey

   Review Open access 21 September 2023 Pages: 4758 - 4776

   

6. Impact of Sodium Zirconium Cyclosilicate Plus Renin–Angiotensin–Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia: OPTIMIZE II Real-World Study

   • Jamie P. Dwyer
   • Abiy Agiro
   • Yemisi Oluwatosin

   Original Research Open access 22 August 2023 Pages: 4777 - 4791

   

7. Prognostic Potential of Pulmonary Hypertension in Patients with Hematologic Malignancy

   • Miaojing Li
   • Manyun Tang
   • Pengcheng He

   Original Research 23 August 2023 Pages: 4792 - 4804

   

8. Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

   • Daniel Q. Huang
   • Veeral Ajmera
   • Rohit Loomba

   Original Research 24 August 2023 Pages: 4805 - 4816

   

9. Real-World Effectiveness and Safety of a Single-Pill Combination of Olmesartan/Amlodipine/Hydrochlorothiazide in Korean Patients with Hypertension and Cardiovascular Risk Factors

   • Jaewon Oh
   • Wonho Kim
   • RESOLVE-INT Investigators

   Original Research Open access 31 August 2023 Pages: 4817 - 4835

   

10. Greenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study

    • Ashraf Alzaabi
    • John P. Bell
    • Ekaterina Maslova

    Original Research Open access 09 September 2023 Pages: 4836 - 4856

    

11. Relationship Between Asthma Control Status and Health-Related Quality of Life in Japan: A Cross-Sectional Mixed-Methods Study

    • Hiroyuki Nagase
    • Risako Ito
    • Takeo Ishii

    Original Research Open access 12 September 2023 Pages: 4857 - 4876

    

12. Incidence of Hypophosphatemia After Intravenous Administration of Iron: A Matching-Adjusted Indirect Comparison of Data from Japanese Randomized Controlled Trials

    • Seiji Fukumoto
    • Tatsunori Murata
    • Richard F. Pollock

    Original Research Open access 13 September 2023 Pages: 4877 - 4888

    

13. Pharmacokinetic and Pharmacodynamic Bioequivalence of Pegfilgrastim-cbqv Delivered via a Prefilled Autoinjector and Prefilled Syringe in Healthy Male Participants

    • Hong Tang
    • Francesca Civoli
    • Barbara Finck

    Original Research Open access 14 September 2023 Pages: 4889 - 4906

    

14. Factors Associated with Topical Medication Instillation Failure in Glaucoma: VRAMS-QPiG Study

    • Masaki Tanito
    • Mihoko Mochiji
    • Daisuke Shii

    Original Research Open access 14 September 2023 Pages: 4907 - 4918

15. Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer

    • Neal D. Shore
    • Bryan A. Mehlhaff
    • Fred Saad

    Original Research Open access 15 September 2023 Pages: 4919 - 4927

    

16. Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase

    • Naoki Inui
    • Yukihiro Toi
    • Tomohide Tamura

    Original Research Open access 16 September 2023 Pages: 4928 - 4944

    

17. Biomarkers-Based Cost-Effectiveness of Toripalimab Plus Chemotherapy for Patients with Treatment-Naive Advanced Non-Small Cell Lung Cancer

    • Huixian Zhang
    • Lanfang Li
    • Qiao Liu

    Original Research 16 September 2023 Pages: 4945 - 4956

    

18. Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study

    • Andrew Menzies-Gow
    • Christopher S. Ambrose
    • Elliot Israel

    Original Research Open access 19 September 2023 Pages: 4957 - 4971

    

19. Xioglican Cream in Italian Patients with Chronic Venous Disease: A Post-Marketing Study Investigating Effects on Clinical and Cutaneous Signs and Symptoms

    • Ida Maria Muratori
    • Francesco Contorno
    • Corrado Amato

    Original Research Open access 19 September 2023 Pages: 4972 - 4986

    

20. Genetic Evidence Supporting a Causal Association Between mTOR-Dependent EIF-4E Circulating Protein Level and Osteoporosis

    • Ting Cheng
    • Yao-Chen Zhang
    • Sheng-Xiao Zhang

    Original Research 20 September 2023 Pages: 4987 - 4998

    

21. Corticosteroid Use and Adherence in Patients Treated with Acthar Gel for Advanced Sarcoidosis

    • Kyle Hayes
    • John Niewoehner
    • George J. Wan

    Original Research Open access 20 September 2023 Pages: 4999 - 5015

    

22. VEIN STEP: A Prospective, Observational, International Study to Assess Effectiveness of Conservative Treatments in Chronic Venous Disease

    • Zoubida Tazi Mezalek
    • Toni Feodor
    • Jorge Hernando Ulloa

    Original Research Open access 20 September 2023 Pages: 5016 - 5036

    

23. Real-World Treatment Patterns Among Patients with Connective Tissue Disorder-Related Pulmonary Arterial Hypertension in the United States: A Retrospective Claims-Based Analysis

    • Therese Sargent
    • Yuen Tsang
    • Patrick Lefebvre

    Original Research Open access 20 September 2023 Pages: 5037 - 5054

    

24. Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetes Mellitus Undergoing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors (EAGLE-DH)

    • Hirohiko Motoki
    • Yoshito Inobe
    • Koichiro Kuwahara

    Original Research Open access 21 September 2023 Pages: 5055 - 5075

    

25. Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis

    • Jacques R. Snyman
    • Freedom Gumedze
    • Ntobeko A. B. Ntusi

    Original Research Open access 21 September 2023 Pages: 5076 - 5089

    

26. The Epidemiology of Palmoplantar Pustulosis: An Analysis of Multiple Health Insurance Claims and Electronic Health Records Databases

    • Darmendra Ramcharran
    • Bruce Strober
    • Amy S. Paller

    Original Research Open access 22 September 2023 Pages: 5090 - 5101

    

27. Real-World Hemoglobin A1c Changes, Prescribing Provider Types, and Medication Dose Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide

    • Monica Frazer
    • Caroline Swift
    • Mico Guevarra

    Original Research Open access 23 September 2023 Pages: 5102 - 5114

    

28. Injection Site Reactions with Long-Term Pegcetacoplan Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Brief Report

    • Vivek Sharma
    • Jamie Koprivnikar
    • Allison Bachelor

    Brief Report Open access 14 September 2023 Pages: 5115 - 5129

29. Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States

    • Chuka Udeze
    • Kristin A. Evans
    • Biree Andemariam

    Correction Open access 11 September 2023 Pages: 5130 - 5130